Mucormycosis: An opportunistic pathogen during COVID-19

I Mahalaxmi, K Jayaramayya, D Venkatesan… - Environmental …, 2021 - Elsevier
The pandemic of coronavirus disease 2019 (COVID-19) still remains on an upsurge trend.
The second wave of this disease has led to panic in many countries, including India and …

Mucormycosis

G Reid, JP Lynch III, MC Fishbein… - Seminars in respiratory …, 2020 - thieme-connect.com
Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

[HTML][HTML] Therapy of mucormycosis

NV Sipsas, MN Gamaletsou, A Anastasopoulou… - Journal of Fungi, 2018 - mdpi.com
Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in
addition to amphotericin B products, to our armamentarium against mucormycosis, many …

Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis

G Chamilos, RE Lewis… - Clinical Infectious …, 2008 - academic.oup.com
Background. Zygomycosis is an emerging opportunistic mycosis among
immunocompromised patients with a particularly poor prognosis. Methods. We analyzed the …

Mucormycosis caused by unusual mucormycetes, non-Rhizopus,-Mucor, and-Lichtheimia species

MZR Gomes, RE Lewis… - Clinical Microbiology …, 2011 - Am Soc Microbiol
SUMMARY Rhizopus, Mucor, and Lichtheimia (formerly Absidia) species are the most
common members of the order Mucorales that cause mucormycosis, accounting for 70 to …

How I treat mucormycosis

DP Kontoyiannis, RE Lewis - … Journal of the American Society of …, 2011 - ashpublications.org
Unlike invasive aspergillosis, the prognosis and outcome of hematologic malignancy
patients who develop invasive mucormycosis have not significantly improved over the past …

Mucormycoses

D Farmakiotis, DP Kontoyiannis - Infectious Disease Clinics, 2016 - id.theclinics.com
The term zygomycosis has been commonly used to describe invasive fungal infections (IFI)
by the Zygomycetes, a term formerly used to describe molds with aseptate or pauciseptate …

Breaking the mold: a review of mucormycosis and current pharmacological treatment options

TT Riley, CA Muzny, E Swiatlo… - Annals of …, 2016 - journals.sagepub.com
Objective: To review the current literature for the pathogenesis of mucormycosis, discuss
diagnostic strategies, and evaluate the efficacy of polyenes, triazoles, and echinocandins as …

[HTML][HTML] Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic

A Sharma, A Goel - Folia Microbiologica, 2022 - Springer
Mucormycosis is a deadly opportunistic disease caused by a group of fungus named
mucormycetes. Fungal spores are normally present in the environment and the immune …

A prospective study of mucormycosis in north India: experience from a tertiary care hospital

K Bala, J Chander, U Handa, RS Punia… - Medical …, 2015 - academic.oup.com
Mucormycosis is an emerging angioinvasive infection caused by the ubiquitous filamentous
fungi of the Order Mucorales and class of Mucormycetes. We conducted a prospective study …